Adler Eric, Chief Medical Officer of Lexeo Therapeutics ($LXEO), made five open market sales of company shares over the past year, totaling about $40,400. His most recent sale occurred on November 18, 2025. These transactions rank 10,596th out of 11,678 individual insiders in our database, far below the average sale value of $8.6 million across 6.4 transactions per insider. Adler Eric recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 615 | $9.27 | 72,646.0000 | 72,987,327 | 0.84% | 0.00% |
| Oct. 15, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | A | Common Stock | 9570 | $0.00 | 76,643.0000 | 33,196,997 | 14.27% | 0.03% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 38 | $9.56 | 73,261.0000 | 33,196,997 | 0.05% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 3344 | $8.94 | 73,299.0000 | 33,196,997 | 4.36% | 0.01% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 608 | $4.67 | 67,073.0000 | 33,196,997 | 0.90% | 0.00% |
| May 16, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 585 | $2.77 | 67,681.0000 | 33,196,997 | 0.86% | 0.00% |
| Feb. 19, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | S | Common Stock | 2359 | $4.41 | 68,266.0000 | 0 | 3.34% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | A | Stock Option (right to buy) | 87500 | $0.00 | 87,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | A | Common Stock | 43750 | $0.00 | 70,625.0000 | 0 | 162.79% | 0.00% |
| Feb. 2, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | A | Common Stock | 26875 | $0.00 | 26,875.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Adler Eric | Chief Medical Officer | A | Employee Stock Option (right to buy) | 161250 | $0.00 | 161,250.0000 | 0 | 9999.99% | 0.00% |